BIOPHEN™ FVIII:C kromogeenne analüüs (2 × 2,5 ml)
Töötlemine...

BIOPHEN™ FVIII:C kromogeenne analüüs (2 × 2,5 ml)

Code: A221402-CAN
Manufacturer’s Part Number: 221402
Toote maht: 2 × 2,5 ml
Luba: CE / HCL

Hind:$525,00

Kogus

Toote kirjeldus

Chromogenic assay for Factor VIII coagulant activity (FVIII:C) in citrated human plasma or therapeutic FVIII concentrates. Uses human Factor IX and Factor X reagents — validated for Emicizumab (Hemlibra®) "FVIII-like" activity measurement. CE-IVD.

  • Two working ranges: low range (0.5–25%) for severe hemophilia A, high range (2–200%) for moderate/mild and concentrates
  • Human FIX/FX design detects Emicizumab (Hemlibra®) FVIII-like activity
  • Traceable to WHO international FVIII standard via BIOPHEN™ Plasma Calibrator (222101)
  • 2 × 2,5 ml pakend

Toote omadused

  • Analüüsi kogukestus: ≤ 10 min
  • Detection Threshold:
      High Range: 10%
      Low Range: 0.2%
  • Dynamic Range:
      High Range: 5 to 200%
      Low Range: 1 to 25%
  • Analüüsi sisene variatsioonikoefitsient (CV): 3–5%
  • Analüüsidevaheline korduvus (CV): 4–7%
  • Number of Tests (Manual Microplate Method): 2 x 50 Tests
  • Reference Material: FVIII:C International Standard

Toote komponendid

  • R1: 2 x 2.5 mL Human FX, lyophilized.
  • R2: 2 × 2,5 ml aktiveerimisreaktiivi, lüofiliseeritud.
  • R3: 2 × 2,5 ml FXa-spetsiifiline kromogeenne substraat (SXa-11), lüofiliseeritud.
  • R4+: 4 x 25 mL Tris-BSA Buffer, ready to use.

Toote kasutusvaldkonnad

Measurement of Factor VIII:C in research applications.

Associated calibrator and controls are available: BIOPHEN™ Plasma Calibrator (Ref A222101-CAN), BIOPHEN™ Normal Control Plasma (Ref A223201-CAN) and BIOPHEN™ Abnormal Control Plasma (Ref A223301-CAN).

Please Note: IVD Not for Sale in US. For US availability CLICK HERE.

Andmeleht/tehnilised andmed